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LETTERS TO THE EDITOR
 
To the Editor—Health-related quality of life (HRQL),
health status, and other specific functional status
assessments that are included udner the umbrella
of PRO (patient-reported outcomes), are increas-
ingly used as efficacy end points in randomized
controlled trials. It is now recognized that, although
perceptual, PROs can be measured in reliable and
valid ways. Indeed, evidence of the scientific sound-
ness of the questionnaire should be provided. In
that sense we fully support Paul Kind’s general
statement “we need demonstrable rigor in our meth-
ods.” Nevertheless, Dr. Kind’s comments raise two
major issues: the perspective taken for scaling, and
the level of data reported in a single manuscript.
 
Scaling
 
It is common practice for multi-item scales in de-
scriptive (psychometric) questionnaires to be scored
using the method of summated ratings. Indeed,
simple summing of scores over the individual items
is the most rational index. This “linear model” ap-
proach works if items are measuring the same
construct, the scaling assumption being based on a
similar distribution of responses to items and simi-
lar item variances. In addition, the internal consis-
tency reliability of the scale is estimated using Cron-
bach’s alpha coefficient. This provides an indication
of the degree of convergence between different items
hypothesized to represent the same construct. Clas-
sic references include Likert [1], Nunnally [2], and
Streiner [3].
This was the perspective we took for the MSF-4,
bearing in mind that the MSF-4 was a descriptive
questionnaire aimed at evaluating the sexual func-
tional status of men with benign prostatic hyper-
trophy (BPH). We actually followed the psycho-
metric criteria described and recommended by the
Medical Outcomes Trust and its Scientific Advi-
sory Committee [4], based on Likert’s [1] theory.
We did not introduce a valuation system (ex-
plicit weights) in the scoring algorithm of the
MSF-4, given that this questionnaire is not a pref-
erence-based instrument and the introduction of
differential weights in a one-domain, multi-item
scale does not seem to provide a substantial ad-
vantage over using the unweighted score, particu-
larly when item-total correlations are similar or
when the reliability is acceptable [5,6]. Furthermore,
improvement in the quality of the items and/or in-
creases in the number of items are generally rec-
ommended ways of improving reliability, rather
than the weighting of items. In addition, major is-
sues related to weighting are still under discussion:
Which method should be used? Whose value should
be taken into account?
 
Level of data displayed in a single manuscript
 
If the first issue raised by Dr. Kind can be consid-
ered as theoretical, or even philosophical, the sec-
ond one is very practical. According to the perspec-
tive taken, the underlying theory, and the context,
authors have to face a difficult choice. What is the
minimum level of data that should be reported in a
single manuscript, taking into account the type of
journal and the numbers of words/tables recom-
mended by the editor? How much evidence should
be provided to demonstrate the appropriateness of
the scoring system and the reliability and validity
of the PRO instrument? One can easily note that,
even though standards of validation are available,
great variability exists in the types of data reported
in manuscripts describing the development and use
of PRO instruments. In particular, details support-
ing the scoring algorithm or the ordinality of item
response categories are not commonly reported.
Following the usual practice, in our manuscript
we decided to put the focus on the clinical validity
of the MSF-4 questionnaire rather than report de-
tails on the scaling assumptions. A great deal more
information is available in the analyses than was
reported in the manuscript. Interested readers can
contact the author for additional details on the
MSF-4 instrument characteristics.
Again, we think the main issue is the absence of
consensus regarding the type of data that should
be shown in a manuscript to support the valida-
tion of a scale. In any case, as stated by Dr. Kind,
we should go beyond Cronbach’s alpha.—Patrick
Marquis, Mapi Values, Lyon, France.
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